Univest Financial Corp Amgen Inc Transaction History

Univest Financial Corp

$1.51 Billion
Q3 2024

A detailed history of Univest Financial Corp transactions in Amgen Inc stock. As of the latest transaction made, Univest Financial Corp holds 17,258 shares of AMGN stock, worth $5.07 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

17,258

Previous 1,383 1147.87%

Holding current value

$5.07 Million

Previous $432,000 1187.04%

% of portfolio

0.37%

Previous 0.12%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $4.91 Million - $5.36 Million	15,875 Added 1147.87%	17,258 $5.56 Million
Q2 2024 Aug 05, 2024	SELL	$262.75 - $319.31 $11,823 - $14,368	-45 Reduced 3.15%	1,383 $432,000
Q1 2024 May 08, 2024	SELL	$268.87 - $324.56 $38,986 - $47,061	-145 Reduced 9.22%	1,428 $406,000
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $13,807 - $15,576	-54 Reduced 3.32%	1,573 $453,000
Q3 2023 Nov 07, 2023	SELL	$218.65 - $271.46 $150,212 - $186,493	-687 Reduced 29.69%	1,627 $437,000
Q2 2023 Aug 07, 2023	SELL	$214.27 - $253.37 $4.41 Million - $5.22 Million	-20,594 Reduced 89.9%	2,314 $513,000
Q1 2023 May 08, 2023	BUY	$225.79 - $275.2 $1.65 Million - $2.02 Million	7,325 Added 47.01%	22,908 $5.54 Million
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $553,794 - $703,662	-2,418 Reduced 13.43%	15,583 $4.09 Million
Q3 2022 Nov 03, 2022	SELL	$224.46 - $253.15 $1.57 Million - $1.77 Million	-6,993 Reduced 27.98%	18,001 $4.06 Million
Q2 2022 Aug 05, 2022	SELL	$230.71 - $256.74 $81,902 - $91,142	-355 Reduced 1.4%	24,994 $6.08 Million
Q1 2022 May 05, 2022	BUY	$219.27 - $242.57 $77,183 - $85,384	352 Added 1.41%	25,349 $6.13 Million
Q4 2021 Feb 08, 2022	SELL	$198.88 - $227.6 $13,523 - $15,476	-68 Reduced 0.27%	24,997 $5.62 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $236,893 - $277,549	1,116 Added 4.66%	25,065 $5.33 Million
Q2 2021 Jul 20, 2021	SELL	$233.58 - $259.14 $211,389 - $234,521	-905 Reduced 3.64%	23,949 $5.84 Million
Q1 2021 Apr 14, 2021	SELL	$221.91 - $258.6 $21,969 - $25,601	-99 Reduced 0.4%	24,854 $6.18 Million
Q4 2020 Jan 19, 2021	BUY	$216.38 - $257.67 $228,280 - $271,841	1,055 Added 4.41%	24,953 $5.74 Million
Q3 2020 Oct 13, 2020	SELL	$234.65 - $260.95 $217,051 - $241,378	-925 Reduced 3.73%	23,898 $6.07 Million
Q2 2020 Jul 09, 2020	SELL	$197.81 - $242.74 $53,606 - $65,782	-271 Reduced 1.08%	24,823 $5.86 Million
Q1 2020 May 05, 2020	BUY	$182.24 - $241.7 $405,301 - $537,540	2,224 Added 9.72%	25,094 $5.09 Million
Q4 2019 Jan 14, 2020	SELL	$189.21 - $243.2 $216,645 - $278,464	-1,145 Reduced 4.77%	22,870 $3.34 Million
Q3 2019 Nov 06, 2019	SELL	$174.11 - $208.62 $61,112 - $73,225	-351 Reduced 1.44%	24,015 $4.65 Million
Q2 2019 Jul 12, 2019	BUY	$166.7 - $195.41 $75,515 - $88,520	453 Added 1.89%	24,366 $4.49 Million
Q1 2019 Apr 09, 2019	BUY	$180.87 - $203.88 $66,741 - $75,231	369 Added 1.57%	23,913 $4.54 Million
Q4 2018 Jan 28, 2019	BUY	$178.4 - $208.25 $63,332 - $73,928	355 Added 1.53%	23,544 $4.58 Million
Q3 2018 Oct 10, 2018	SELL	$185.29 - $208.89 $126,923 - $143,089	-685 Reduced 2.87%	23,189 $4.81 Million
Q2 2018 Jul 17, 2018	SELL	$166.05 - $186.51 $133,172 - $149,581	-802 Reduced 3.25%	23,874 $4.41 Million
Q1 2018 Apr 19, 2018	SELL	$169.43 - $198.0 $120,634 - $140,976	-712 Reduced 2.8%	24,676 $4.21 Million
Q4 2017 Jan 22, 2018	BUY	$168.79 - $188.59 $101,274 - $113,154	600 Added 2.42%	25,388 $4.42 Million
Q3 2017 Oct 13, 2017	BUY	$167.29 - $191.0 $4.15 Million - $4.73 Million	24,788	24,788 $4.62 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Univest Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Univest Financial Corp with notifications on news.

Account

Univest Financial Corp Amgen Inc Transaction History